Literature DB >> 11861380

The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.

Christopher A Haiman1, Myles Brown, Susan E Hankinson, Donna Spiegelman, Graham A Colditz, Walter C Willett, Philip W Kantoff, David J Hunter.   

Abstract

Shorter alleles of a polymorphic [CAG](n) repeat in exon 1 of the androgen receptor (AR) have been associated with increased risk of prostate cancer and decreased risk of breast cancer. We prospectively assessed the association between the [CAG](n) repeat polymorphism in the androgen receptor and breast cancer risk among Caucasian women in a case-control study nested within the Nurses' Health Study cohort (cases, n = 727; controls, n = 969). In addition, we assessed whether androgen receptor genotype influences endogenous steroid hormone levels in women and whether the associations between androgen receptor alleles and breast cancer risk differed according to established breast cancer risk factors. Women with one or more long AR [CAG](n) repeat alleles (>or=22 repeats) were not at increased risk of breast cancer [odds ratio (OR), 1.06; 95% confidence interval (CI), 0.83-1.35]. Significant associations were not observed between AR genotypes comprised of two short alleles ([CAG](n) <or=20 versus both alleles >or=22: OR, 0.92; 95% CI, 0.62-1.36) or two long alleles ([CAG](n) >or= 25 versus both alleles <or= 22: OR, 1.42; 95% CI, 0.81-2.50) and breast cancer risk. We also observed no strong overall association between average repeat length and breast cancer risk (OR, 1.04 per CAG repeat; 95% CI, 0.99-1.10) or between average repeat length and plasma hormone levels. We also examined the cross-classification of AR genotype and first-degree family history of breast cancer. Compared with women with both alleles <22 and no family history, we observed a significant positive association limited to women with both a first-degree family history of breast cancer and longer alleles (one or two [CAG](n) alleles >or=22; OR, 1.70; 95% CI, 1.20-2.40; P for interaction = 0.04). In summary, we observed no overall relation of AR genotype with breast cancer risk among mostly postmenopausal Caucasian women. However, these data suggest that longer AR [CAG](n) repeat alleles may increase breast cancer risk among women with a first-degree family history of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861380

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer.

Authors:  Andrei Anghel; Marius Raica; Catalin Marian; Sorin Ursoniu; Oana Mitrasca
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-22       Impact factor: 4.553

2.  Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk.

Authors:  Kathryn L Terry; Immaculata De Vivo; Linda Titus-Ernstoff; Mei-Chiung Shih; Daniel W Cramer
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

3.  Androgen receptor CAG repeat length and risk of biliary tract cancer and stones.

Authors:  Tamra E Meyer; Thomas G O'Brien; Gabriella Andreotti; Kai Yu; Qizhai Li; Yu-Tang Gao; Asif Rashid; Ming-Chang Shen; Bing-Sheng Wang; Tian-Quan Han; Bai-He Zhang; Shelley Niwa; Joseph F Fraumeni; Ann W Hsing
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-03       Impact factor: 4.254

4.  Selected estrogen receptor 1 and androgen receptor gene polymorphisms in relation to risk of breast cancer and fibrocystic breast conditions among Chinese women.

Authors:  Lori C Sakoda; Christie R Blackston; Jennifer A Doherty; Roberta M Ray; Ming Gang Lin; Dao Li Gao; Helge Stalsberg; Ziding Feng; David B Thomas; Chu Chen
Journal:  Cancer Epidemiol       Date:  2010-09-17       Impact factor: 2.984

Review 5.  Trinucleotide repeat expansions in human breast cancer-susceptibility genes: relevant targets for aspirin chemoprevention?

Authors:  M A Altinoz; N E Tunalı
Journal:  Clin Transl Oncol       Date:  2015-07-22       Impact factor: 3.405

Review 6.  Androgens and the breast.

Authors:  Constantine Dimitrakakis; Carolyn Bondy
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

7.  Androgen receptor status predicts response to chemotherapy, not risk of breast cancer in Indian women.

Authors:  Pranjal Kulshreshtha; Anurupa Chakraborty; Lc Singh; Ashwani K Mishra; Dinesh Bhatnagar; Sunita Saxena
Journal:  World J Surg Oncol       Date:  2010-08-04       Impact factor: 2.754

8.  Secondary structure at a hot spot for DNA methylation in DNA from human breast cancers.

Authors:  Jarrod Clark; Steven S Smith
Journal:  Cancer Genomics Proteomics       Date:  2008 Sep-Oct       Impact factor: 4.069

9.  Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women.

Authors:  Yonglan Zheng; Dezheng Huo; Jing Zhang; Toshio F Yoshimatsu; Qun Niu; Olufunmilayo I Olopade
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

10.  Androgen receptor polyglutamine repeat number: models of selection and disease susceptibility.

Authors:  Calen P Ryan; Bernard J Crespi
Journal:  Evol Appl       Date:  2012-06-11       Impact factor: 5.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.